ICN Sells Biomed Unit to Founder Panic
- Share via
ICN Pharmaceuticals Inc. of Costa Mesa said it sold its biomedical research and diagnostic business to its former chairman and founder, Milan Panic, for about $15 million.
Panic purchased the division through his newly formed private company, MP Global of Irvine, using the approximately 1 million shares of ICN stock he owned.
As part of the deal, MP Global will get a Boeing 737 jet that was converted for corporate use. A smaller ICN jet was sold in November. The diagnostics division, based in Irvine, employs 350 people and had 2002 sales of $42 million.
ICN shares fell 6 cents to $16.70 on the NYSE.
-- Ronald D. White
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.